|
|
HIPAAdvisor: Q & A with Steve Fox, Esq.
How Fundraising and Marketing Fit Into HIPAA Privacy
QUESTION: Does the Privacy standard permit the use and disclosure
of protected health information ("PHI") for the purposes
of fundraising and marketing?
ANSWER: Yes. In certain circumstances PHI may be used for
marketing or fundraising without an authorization.
Covered entities must have written authorization to use or disclose
PHI for purposes that are unrelated to the treatment, payment, or
the health care operations of the covered entity. Originally, this
requirement was applicable to all uses and disclosures of PHI for
marketing and fundraising purposes.
Under the final Privacy rule, however, certain marketing and fundraising
activities have been included in the definition of "health
care operations;" thereby allowing covered entities to use
and disclose PHI without patient authorization in support of several
limited fundraising and marketing activities. The definition of
health care operations under the proposed rule included only those
operations sufficiently related to treatment and payment to warrant
the use and disclosure of PHI without authorization. However, in
the final rule, the definition was revised to include those general
administrative and business functions necessary for covered entities
to remain a viable business. Therefore, business management activities
and general administrative functions, such as specific fundraising
and marketing activities, are included as part of the definition
of a covered entity's "health care operations."
Covered entities, their business associates, or institutionally
related foundations (foundations that qualify as nonprofit charitable
foundations under section 501(c)(3) of the Internal Revenue Code
and that have in their charter statement of charitable purposes
an explicit linkage to the covered entity), may use or disclose
an individual's demographic information and/or the dates that the
individual received treatment without obtaining written authorization.
These uses and disclosures are
permissible as long as:
- the covered entity's notice of privacy practices state that
individuals may be contacted for the purpose of raising funds,
- any and all fundraising materials include instructions on how
to opt-out of future communications, and (iii) the covered entity
makes reasonable efforts to ensure that individuals' opt-out requests
are honored.
The use or disclosure of PHI for marketing purposes is permissible
without an authorization in three instances:
- First, covered entities are permitted to use or disclose PHI
without authorization to make marketing communications in face-to-face
encounters. These communications may include discussion of any
services or products, including the services or products of a
third-party.
- Second, PHI may be used or disclosed without authorization
to make marketing communications involving products or services
of nominal value. This would allow for the distribution of calendars,
pens and other merchandise that is generally considered to be
of a promotional nature.
- Finally, no authorization is required for marketing communications
about health related products or services of the covered entity
or a third party, if the communication:
- identifies the covered entity as the party making the communication,
- discloses any direct or indirect remuneration received by
the covered entity for making the communication,
- contains instructions on how to opt-out of similar future
communications, and
- explains why the individual has been targeted for the communication
in those instances where PHI was used to target the communication
to particular individuals based upon their health status or
condition.
This third type of marketing communication is restricted to uses
by covered entities or disclosures to their business associates
pursuant to a business associate agreement.
Read past HIPAA Legal Q/A articles.
Steve Fox, Esq., is a partner in the Washington, D.C.
office of Pepper Hamilton LLP. Pepper Hamilton LLP is a multi-practice law firm
with more than 400 lawyers in ten offices. A specialist in healthcare, Steve is
a frequent writer and speaker on healthcare information management and technology
issues. www.pepperlaw.com/
This article was co-authored by Rachel H. Wilson, Esq., an associate at Pepper
Hamilton.
Disclaimer: Steve's responses offer information that is general in nature and
should not be relied upon as legal advice. Only your attorney is qualified to
evaluate your specific situation and provide you with customized advice.
Have a question you'd like Steve to discuss in HIPAAlert? Send it to
and he'll be glad to consider using it in a future column, with or without attribution.
|
 |
 |